PFE
NYSEPFIZER INC
Health Care, Pharmaceuticals
$26.76
close 7 Aug 2026
+8.87%
52-week change
$152.52B
market cap
$23.58
$28.75
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $63.70B | $62.58B | $63.63B | $59.55B | $101.18B | $81.29B | $41.65B | $40.91B | $40.83B | $52.55B | $52.82B | $48.85B | $49.61B | $51.58B | $54.66B | $61.04B | $65.17B | $49.27B | $48.30B | $48.42B |
| Cost of revenue | $17.08B | $16.07B | $17.85B | $24.95B | $34.34B | $30.82B | $8.48B | $8.05B | $8.99B | $11.23B | $12.32B | $9.65B | $9.58B | $9.59B | $9.82B | $12.50B | $14.79B | $8.46B | $8.11B | $11.24B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $11.05B | $10.44B | $10.82B | $10.68B | $11.43B | $10.36B | $8.71B | $8.39B | $7.76B | $7.68B | $7.89B | $7.69B | $8.39B | $6.68B | $7.48B | $8.68B | $9.48B | $7.82B | $7.95B | $8.09B |
| SG&A | $13.72B | $13.79B | $14.73B | $14.77B | $13.68B | $12.70B | $11.60B | $12.73B | $12.61B | $14.80B | $14.84B | $14.81B | $14.10B | $14.36B | $15.17B | $17.58B | $18.97B | $14.75B | $14.54B | $15.63B |
| Operating income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest expense | $2.70B | $2.67B | $3.09B | $2.21B | $1.24B | $1.29B | $1.45B | $1.57B | $1.32B | $1.27B | $1.19B | $1.20B | $1.36B | $1.41B | $1.52B | $1.68B | $1.80B | $1.23B | $516.00M | — |
| Tax expense | -$164.00M | -$266.00M | -$28.00M | -$1.12B | $3.33B | $1.85B | $370.00M | $583.00M | -$266.00M | -$9.05B | $1.12B | $1.99B | $3.12B | $4.31B | $2.22B | $3.62B | $1.15B | $2.15B | $1.65B | $1.02B |
| Net income | $4.33B | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B | $9.16B | $16.03B | $11.15B | $21.31B | $7.22B | $6.96B | $9.14B | $22.00B | $14.57B | $10.01B | $8.26B | $8.64B | $8.10B | $8.14B |
| Diluted EPS | $0.7600 | $1.36 | $1.41 | $0.3700 | $5.47 | $3.85 | $1.63 | $2.82 | $1.87 | $3.52 | $1.17 | $1.11 | $1.42 | $3.19 | $1.94 | $1.27 | $1.02 | $1.23 | $1.20 | $1.17 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net margin | 6.80% | 12.42% | 12.62% | 3.56% | 31.01% | 27.04% | 21.99% | 39.18% | 27.32% | 40.55% | 13.66% | 14.25% | 18.42% | 42.65% | 26.66% | 16.40% | 12.67% | 17.53% | 16.78% | 16.82% |
filed 4 Aug 2026